MUSC Hollings Cancer Center is the only NCI-designated cancer center in South Carolina. Specialists from more than 20 academic departments work together to study and treat cancer through three programs: the cancer biology and immunology, cancer control and therapeutics development. Clinicians and researchers also focus on cutting-edge research; the center supports more than 200 clinical trials and has an annual research funding portfolio of more than $44 million.
